• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  10/30/2007
Trade Name:  Combigan 0.2%/0.5% ophthalmic solution
Generic Name or Proper Name (*):  brimonidine tartrate/timolol maleate
Indications Studied:  Reduction of elevated intraocular pressure in patients with glaucoma or ocular hypertension
Label Changes Summary:  * Safety and effectiveness supported by evidence from clinical studies in adults with additional data from a study in children with glaucoma ages 2  7 years old * Not recommended for use in children under the age of 2 years due to safety concerns based on reports of apnea, bradycardia, hypotension, hypothermia, hypotonia, and somnolence in infants * Safety and effectiveness have not been studied in children below the age of two years * New active ingredient
Product Labeling:  Labeling  Opens a new window
Sponsor:  Allergan
Therapeutic Category:  Ophthalmologic hypotensive